CONFERENCE PROCEEDINGS
Advanced Search
Home > Proceedings > Volume 9691 > Article
Presentation
27 April 2016 Multimodal imaging of lung cancer and its microenvironment (Conference Presentation)
Lida P. Hariri M.D., Matthew J. Niederst, Hillary Mulvey, David C. Adams, Haichuan Hu, Isabel Chico Calero, Margit V. Szabari M.D., Benjamin J. Vakoc, Tayyaba Hasan, Brett E. Bouma, Jeffrey A. Engelman M.D., Melissa J. Suter
Author Affiliations +
Proceedings Volume 9691, Endoscopic Microscopy XI; and Optical Techniques in Pulmonary Medicine III; 96911F (2016) https://doi.org/10.1117/12.2214658
Event: SPIE BiOS, 2016, San Francisco, California, United States
Abstract
Despite significant advances in targeted therapies for lung cancer, nearly all patients develop drug resistance within 6-12 months and prognosis remains poor. Developing drug resistance is a progressive process that involves tumor cells and their microenvironment. We hypothesize that microenvironment factors alter tumor growth and response to targeted therapy. We conducted in vitro studies in human EGFR-mutant lung carcinoma cells, and demonstrated that factors secreted from lung fibroblasts results in increased tumor cell survival during targeted therapy with EGFR inhibitor, gefitinib. We also demonstrated that increased environment stiffness results in increased tumor survival during gefitinib therapy. In order to test our hypothesis in vivo, we developed a multimodal optical imaging protocol for preclinical intravital imaging in mouse models to assess tumor and its microenvironment over time. We have successfully conducted multimodal imaging of dorsal skinfold chamber (DSC) window mice implanted with GFP-labeled human EGFR mutant lung carcinoma cells and visualized changes in tumor development and microenvironment facets over time. Multimodal imaging included structural OCT to assess tumor viability and necrosis, polarization-sensitive OCT to measure tissue birefringence for collagen/fibroblast detection, and Doppler OCT to assess tumor vasculature. Confocal imaging was also performed for high-resolution visualization of EGFR-mutant lung cancer cells labeled with GFP, and was coregistered with OCT. Our results demonstrated that stromal support and vascular growth are essential to tumor progression. Multimodal imaging is a useful tool to assess tumor and its microenvironment over time.
Conference Presentation
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Citation Download Citation
Lida P. Hariri M.D., Matthew J. Niederst, Hillary Mulvey, David C. Adams, Haichuan Hu, Isabel Chico Calero, Margit V. Szabari M.D., Benjamin J. Vakoc, Tayyaba Hasan, Brett E. Bouma, Jeffrey A. Engelman M.D., and Melissa J. Suter "Multimodal imaging of lung cancer and its microenvironment (Conference Presentation)", Proc. SPIE 9691, Endoscopic Microscopy XI; and Optical Techniques in Pulmonary Medicine III, 96911F (27 April 2016); https://doi.org/10.1117/12.2214658
ACCESS THE FULL ARTICLE
ORGANIZATIONAL
Sign in with credentials provided by your organization.
INSTITUTIONAL
Select your institution to access the SPIE Digital Library.
SELECT YOUR INSTITUTION
PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
PERSONAL SIGN IN
No SPIE Account? Create one
PURCHASE THIS CONTENT
SUBSCRIBE TO DIGITAL LIBRARY
50 downloads per 1-year subscription
Members: $195
Non-members: $335 ADD TO CART
25 downloads per 1 - year subscription
Members: $145
Non-members: $250 ADD TO CART
PURCHASE SINGLE ARTICLE
Includes PDF, HTML & Video, when available
Members: $17.00
Non-members: $21.00 ADD TO CART
PROCEEDINGS
 PRESENTATION
WATCH
PRESENTATION SAVE TO MY LIBRARY
GET CITATION
Advertisement
Advertisement
KEYWORDS
Tumors
Multimodal imaging
Lung cancer
Optical coherence tomography
Therapeutics
Lung
Resistance
RELATED CONTENT
Subscribe to Digital Library
Receive Erratum Email Alert
Back to Top